News|Articles|December 2, 2025

Mindray Debuts Resona A20 Premium Ultrasound Device at RSNA

The Resona A20 device reportedly provides advances in imaging and AI automation along with an intuitive ergonomic design for ease of use.

Offering a combination of enhanced image clarity, intuitive design and automated tools to facilitate smoother workflows, Mindray introduced the Resona A20 ultrasound system at the Radiological Society of North America (RSNA) conference.

Mindray noted that the Resona A20 provides ultra-wideband coverage and enhanced acoustic focusing and its FreeBeam beamforming technology enables improved precision with echo data.

Other features of the Resona A20 ultrasound platform include an adjustable control panel, a collapsible 27-inch monitor for ease of transport and an interface that allows clinicians to utilize customizable AI-powered profiles to bolster workflow efficiency, according to Mindray.

“(The Resona A20) delivers power through simplicity, elegance through intelligence, and performance that truly elevates the standard of care,” noted Maher Elhihi, the vice president of imaging marketing and corporate communications at Mindray North America.

For Related Content

• “Samsung to Unveil AI-Powered R20 Ultrasound System at RSNA”

• “New AI-Powered Ultrasound Feature May Enhance Planning for Peripheral IV Procedures”

• “Can a New AI-Powered Point-of-Care Ultrasound Platform Enhance Reporting Efficiency and Compliance?”

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Related to this article

October 19th, 2026

How AI, Theranostics and More Empowered Patients Have Led to Significant Changes in Radiology

In a recent interview, Phillip Koo, MD, discussed emerging trends with AI, theranostics and empowered patients, and how these developments may lead to challenges and potential opportunities for radiologists and nuclear medicine physicians.

October 12th, 2026

Key Sessions of Interest for Radiologists at the Upcoming HLTH USA Conference

How will generative AI software be evaluated by the FDA in the future? What’s next for point-of-care ultrasound? What steps have been successful in facilitating adoption of AI applications across enterprise systems? Leaders in radiology and health care will be discussing these topics and more at the upcoming HLTH USA conference.

October 9th, 2026

The Reading Room Podcast: Current Perspectives, Challenges and Possibilities with AI in Breast Imaging, Part 3

In the third of a three-part podcast episode, Wendie Berg, MD, PhD, FACR, FSBI, Manisha Bahl, MD, and Amy Patel, MD discuss recent developments with autonomous AI in breast imaging and share their perspective on the overall potential of AI to help mitigate the radiologist shortage.

October 9th, 2026

What New Dosimetry Data Reveals About 177Lu-Edotreotide for GEP-NET Treatment

In a recent interview, Amir Iravani, MD, FRACP, discussed the radiotherapeutic agent 177Lu-edotreotide and new dosimetry data from the COMPETE trial that was recently presented at the ASTRO conference.

October 5th, 2026

The Reading Room Podcast: Current Perspectives, Challenges and Possibilities with AI in Breast Imaging, Part 2

In the second of a three-part podcast episode, Wendie Berg, MD, PhD, FACR, FSBI, Manisha Bahl, MD, and Amy Patel, MD discuss how to handle disagreements with adjunctive AI in breast imaging, whether to include AI assessments in PACS, and whether patients should pay for the use of adjunctive AI.

September 29th, 2026

ASTRO: What New Phase 3 Research Reveals About SBRT for Patients with Localized Prostate Cancer

For patients with localized prostate cancer, stereotactic body radiotherapy (SBRT) offered comparable freedom from biochemical/clinical failure at eight years and nearly 40 percent lower urinary incontinence in comparison to radical prostatectomy, according to research presented at the ASTRO conference.

October 21st, 2026

The Reading Room Podcast: Emerging Concepts with AI Integration in Radiology

In a new podcast episode, Joseph Cavallo, MD, MBA, offered his perspective on AI integration, potential efficiency gains, navigating post-deployment monitoring and how to incorporate AI literacy into radiology resident training.

October 21st, 2026

FDA Clears AI-Enabled FFR-IQ Software for Estimating Fractional Flow Reserve from CCTA

The FFR-IQ software recently demonstrated a 92.2 percent sensitivity for non-invasive estimation of fractional flow reserve (FFRC) based on coronary CT angiography (CCTA) scans.

Mindray Debuts Resona A20 Premium Ultrasound Device at RSNA

For Related Content

Related to this article

Trending on Diagnostic Imaging

FDA Clears MRI-Based AI Software for Prognostic Evaluation of Patients with Mild Cognitive Impairment

Can MRI-Based AI Have an Impact in Reducing Unnecessary Prostate Biopsies?

FDA Clears AI-Enabled FFR-IQ Software for Estimating Fractional Flow Reserve from CCTA

Can the Kaiser Score with Breast MRI Improve Clarity for BI-RADS 0 and 4 Assessments on Mammography and Ultrasound?

How AI, Theranostics and More Empowered Patients Have Led to Significant Changes in Radiology